ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,765
0,16%
Bitcoin
59 596,55
0,80%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sarepta Therapeutics Inc New (SRPT)

  7. Sarepta Therapeutics Inc New (SRPT) Actualités

SRPT Sarepta Therapeutics Inc New

130,63
-0,27 (-0,21%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Sarepta Therapeutics Inc New SRPT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,27 -0,21% 130,63 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
140,00 130,05 142,79 130,63 130,90
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202422:05BWSarepta Therapeutics Announces First Quarter 2024 Financial..
01/5/202400:38BWSarepta Therapeutics Announces Inducement Grants Under..
24/4/202414:30BWSarepta Therapeutics to Announce First Quarter 2024..
29/3/202421:00BWSarepta Therapeutics Announces Inducement Grants Under..
08/3/202423:38EDGAR2Form 144 - Report of proposed sale of securities
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:34EDGAR2Form 144 - Report of proposed sale of securities
04/3/202414:30BWSarepta Therapeutics to Present at Upcoming Investor..
02/3/202401:55EDGAR2Form 144 - Report of proposed sale of securities
02/3/202401:42EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:47EDGAR2Form 144 - Report of proposed sale of securities
01/3/202400:16BWSarepta Therapeutics Announces Inducement Grants Under..
29/2/202415:00BWSarepta Therapeutics Announces Call for Applications for the..
28/2/202422:05BWSarepta Therapeutics Announces Fourth Quarter and Full-Year..
21/2/202414:30BWSarepta Therapeutics to Announce Fourth Quarter and..
16/2/202413:00BWSarepta Therapeutics Announces U.S. FDA Acceptance of an..
13/2/202419:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202400:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202400:29BWSarepta Therapeutics Announces Inducement Grants Under..
29/1/202413:00BWSarepta Therapeutics Announces Positive Data from Part B of..
16/1/202415:02BWSarepta Therapeutics Initiates Screening in EMERGENE, a..
08/1/202418:08EDGAR2Form 8-K - Current report
08/1/202417:55BWSarepta Therapeutics Reports Preliminary* Fourth Quarter and..
02/1/202414:30BWSarepta Therapeutics to Present at the 42nd Annual J.P...
30/12/202300:27BWSarepta Therapeutics Announces Inducement Grants Under..
22/12/202314:00BWSarepta Therapeutics Submits Efficacy Supplement to Expand..
06/12/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202300:34BWSarepta Therapeutics Announces Inducement Grants Under..
21/11/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202313:30BWSarepta Therapeutics to Present at the UBS Biopharma..
01/11/202321:05BWSarepta Therapeutics Announces Third Quarter 2023 Financial..
01/11/202321:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202300:02BWSarepta Therapeutics Announces Inducement Grants Under..
30/10/202322:17DJNSarepta Therapeutics to Request Expansion of Elevidys to All..

Dernières Valeurs Consultées

NASDAQ
SRPT
Sarepta Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés